David Bharucha - 27 Jan 2025 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Chief Medical Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MIST
Transactions as of
27 Jan 2025
Net transactions value
$0
Form type
4
Filing time
29 Jan 2025, 16:15:10 UTC
Previous filing
17 Feb 2023
Next filing
15 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Employee Stock Option (right to buy) Award $0 +120,600 $0.000000 120,600 27 Jan 2025 Common Shares 120,600 $2.02 Direct F1
transaction MIST Restricted Stock Unit Award $0 +80,400 $0.000000 80,400 27 Jan 2025 Common Shares 80,400 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F2 Each restricted stock unit represents a contingent right to receive one common share.
F3 One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date.